share_log

申联生物(688098.SH)主要股东UBI拟减持不超3%

UBI, the main shareholder of 688098.SH, intends to reduce its holdings by no more than 3%.

智通財經 ·  Dec 27, 2021 03:16

Zhitong Financial APP News, Shenlian Biology (688098.SH) announced that the company's shareholders, United Biopharmaceuticals ("UBI"), intend to reduce their holdings of no more than 12.3193 million shares of the company through centralized bidding and bulk trading, that is, no more than 3 per cent of the company's total share capital.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment